These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36259273)

  • 1. A novel allosteric site employs a conserved inhibition mechanism in human kidney-type glutaminase.
    Shankar S; Ramachandran S; Tulsian N; Radhakrishnan S; Jobichen C; Sivaraman J
    FEBS J; 2023 May; 290(9):2437-2448. PubMed ID: 36259273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.
    Thangavelu K; Pan CQ; Karlberg T; Balaji G; Uttamchandani M; Suresh V; Schüler H; Low BC; Sivaraman J
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7705-10. PubMed ID: 22538822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).
    Thangavelu K; Chong QY; Low BC; Sivaraman J
    Sci Rep; 2014 Jan; 4():3827. PubMed ID: 24451979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for exploring the allosteric inhibition of human kidney type glutaminase.
    Ramachandran S; Pan CQ; Zimmermann SC; Duvall B; Tsukamoto T; Low BC; Sivaraman J
    Oncotarget; 2016 Sep; 7(36):57943-57954. PubMed ID: 27462863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.
    Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP
    J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase.
    Yang KY; Wu CR; Zheng MZ; Tang RT; Li XZ; Chen LX; Li H
    Bioorg Chem; 2019 Nov; 92():103186. PubMed ID: 31465967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells.
    Zhu M; Fang J; Zhang J; Zhang Z; Xie J; Yu Y; Ruan JJ; Chen Z; Hou W; Yang G; Su W; Ruan BH
    Anal Chem; 2017 Feb; 89(3):1689-1696. PubMed ID: 28208301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase.
    Zimmermann SC; Duvall B; Tsukamoto T
    J Med Chem; 2019 Jan; 62(1):46-59. PubMed ID: 29969024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.
    McDonald CJ; Acheff E; Kennedy R; Taylor L; Curthoys NP
    Neurochem Int; 2015 Sep; 88():10-4. PubMed ID: 25510640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
    Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.
    Pasquali CC; Islam Z; Adamoski D; Ferreira IM; Righeto RD; Bettini J; Portugal RV; Yue WW; Gonzalez A; Dias SMG; Ambrosio ALB
    J Biol Chem; 2017 Jul; 292(27):11572-11585. PubMed ID: 28526749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators.
    Stalnecker CA; Erickson JW; Cerione RA
    J Biol Chem; 2017 Apr; 292(15):6095-6107. PubMed ID: 28196863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor.
    Cheng L; Wu CR; Zhu LH; Li H; Chen LX
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1243-1246. PubMed ID: 28174105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.
    Chen Z; Li D; Xu N; Fang J; Yu Y; Hou W; Ruan H; Zhu P; Ma R; Lu S; Cao D; Wu R; Ni M; Zhang W; Su W; Ruan BH
    J Med Chem; 2019 Jan; 62(2):589-603. PubMed ID: 30543285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel tellurodibenzoic acid compounds as kidney-type glutaminase (KGA) inhibitors.
    Hou W; Zhou Y; Rui J; Bai R; Bhasin AKK; Ruan BH
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1673-1676. PubMed ID: 31076348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.
    Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J
    J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).
    Robinson MM; McBryant SJ; Tsukamoto T; Rojas C; Ferraris DV; Hamilton SK; Hansen JC; Curthoys NP
    Biochem J; 2007 Sep; 406(3):407-14. PubMed ID: 17581113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.
    Li Y; Ramachandran S; Nguyen TT; Stalnecker CA; Cerione RA; Erickson JW
    J Biol Chem; 2020 Jan; 295(5):1328-1337. PubMed ID: 31871054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation.
    Katt WP; Ramachandran S; Erickson JW; Cerione RA
    Mol Cancer Ther; 2012 Jun; 11(6):1269-78. PubMed ID: 22496480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
    Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
    Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.